Women's Health Diagnostics Market Growth & Forecast [2031]
Women's Health Diagnostics Market Growth & Forecast [2031]
Segments - Women’s Health Diagnostics Market by Applications (Cancer, Infectious Disease, Osteoporosis, Pregnancy, and Prenatal), End-users (Hospital & Diagnostics Centers and Home), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031
Upcoming
| Report ID :HC-1071
| 4.5 Rating
| 64 Reviews
| 180 Pages
| Format :
Report Description
Women’s Health Diagnostics Market Outlook 2031
The global women’s health diagnostics market size was valued at USD 17.80 Billion in 2022 and is projected to reach USD 33.56 Billion by 2031 at a substantial CAGR of 7.3% during the forecast period, 2023–2031. The growth of the market is attributed to the increasing prevalence of infectious diseases such as hepatitis and urinary tract infection among women.
The demand for various health diagnostic tests from women has considerably increased due to rising number of health-conscious population across the globe. Awareness about early detection of health conditions and issues is increasingly popular and critical to avoid the severe consequences of illness or diseases. Women’s health diagnostics are widely conducted using several digital and mobile technology such as breast MRI, bone density testing, and ultrasound.
Recent technological advancement in the field of medical science is creating various opportunities for the market growth. As per a data published by the National Center for Biotechnology Information (NCBI), women are 30% more prone to be infected with HIV as compared to men.
According to National Institutes of Health (NIH), around 40% of women are likely to contract at least one urinary tract infection (UTI) in their lifetime. It further indicates, women aged under 50 years are 30 times more likely to develop a UTI as compared to men. In the US, women suffering from UTIs register 8.1 million visits to healthcare providers every year.
Breast cancer is the most commonly occurred among women. In 2018, around 2 million new cases were found across the globe. The rising number of chronic illness and growing prevalence of infection diseases among women have substantially raised the demand for the development of miniature diagnostic devices. Moreover, increasing investment in the healthcare infrastructure in emerging economies are expected to create various opportunities for the market growth.
Women’s Health Diagnostics Market Drivers, Restraints, Trends, and Opportunities
- Growing prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer are the key factors driving the growth of women’s health diagnostics market.
- Growing adoption of point of care diagnostic testing and increase advancement in the number of diagnostic and imaging devices are projected to boost the market growth.
- Stringent regulatory guidelines, lack of skill laboratory technicians, and high cost of diagnostic imaging systems are a few key factors restraining the market growth.
- Growing awareness regarding various health-related disorders, prevalence of chronic and lifestyle disorders and infectious diseases across the globe is driving the market growth.
- The outbreak of COVID-19 pandemic has impacted several pharmaceutical players to focus on developing diagnostic kits to undergo diagnostic virology. The rising demand for diagnostic kits globally is projected to boost the market expansion.
Scope of Women’s Health Diagnostics Market Report
The report on the women’s health diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Women’s Health Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Applications (Cancer, Infectious Disease, Osteoporosis, Pregnancy and Prenatal) and End-users (Hospital & Diagnostics Centers and Home) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Siemens Healthcare Private Limited, Hologic, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., bioMérieux SA, Koninklijke Philips N.V., Abbott, and BD. |
Women’s Health Diagnostics Market Segment Insights
Application Segment Analysis
On the basis of applications, the market is segmented into cancer, infectious disease, osteoporosis, pregnancy, and prenatal. The cancer segment is projected to represent a considerable market share during the forecast period owing to the wide introduction of technically advanced hybrid imaging instruments that can ensure higher efficiency and accuracy.
Rising cases of various types of cancer among women especially breast cancer and increasing incidence of several complicacies during pregnancy are key drivers for the segment growth.
End-users Segment Analysis
Based on end-users, the market is bifurcated into hospitals & diagnostics centers and home. The hospitals & diagnostics centers segment is anticipated to constitute a large market share during the forecast period. Hospitals and diagnostics centers are generally the first choice of patients for detection of cancer, infectious diseases, osteoporosis, and others.
On the other hand, the home segment is expected to expand at an impressive CAGR during the forecast period. The increasing investments by market players for commercialization of portable and point of care devices are driving the home segment growth. Additionally, growing awareness regarding home diagnostic devices is projected to further boost the segment growth during the forecast period.
Regional Outlook
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to account for a significant market share during the forecast period owing to the high adoption of technologically advanced products, new product launches, and several government initiatives in the region.
For instance, in September 2017, Philips announced the launch of new ultrasound innovative products such as Philips EPIQ 7, EPIQ 5, and Affiniti 70 ultrasound systems to ensure earlier, easier, and reliable diagnosis. In the US, Home Access Health launched a home testing kit that can be used to obtain a sample and send it to a laboratory for testing for effective diagnosis.
The market in Asia Pacific, however, is anticipated to expand at a high CAGR during the forecast period. Rising awareness and improving healthcare infrastructure regarding women’s health disorders and various governments’ initiatives are expected to positively impact the regional growth of the market.
For instance, the Government of India launched a program called, Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) scheme in November 2016 with an aim to provide free health checkups to pregnant women. This scheme could be a major step enabling women to get tested for high blood sugar (gestational diabetes), anemia, blood pressure, hormonal disorders, and have free access to ultrasounds.
Meanwhile, the market in Latin America region is also expected to register an impressive growth rate during the forecast period. Brazil and Mexico are the key markets in Latin America. The growth of the region is attributed to the declining maternal mortality rate, increasing life expectancy, aging women population, and growing prevalence of infectious & chronic diseases.
Segments
The global women’s health diagnostics market has been segmented on the basis of
Applications
- Cancer
- Infectious Disease
- Osteoporosis
- Pregnancy
- Prenatal
End-users
- Hospital & Diagnostics Centers
- Home
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Siemens Healthcare Private Limited
- Hologic, Inc.
- GE Healthcare
- F. Hoffmann-La Roche Ltd.
- bioMérieux SA
- Koninklijke Philips N.V.
- Abbott
- BD.
Competitive Landscape
Some of the key players in the global women’s health diagnostics market are Siemens Healthcare Private Limited, Hologic, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., bioMérieux SA, Koninklijke Philips N.V., Abbott, and BD.
Key industry participants are providing their focus on various business strategies such as mergers & acquisitions, partnerships, and expansion of regional presence. Various business strategies adopted by the key players such as product launches, expansion, mergers & acquisitions, and certain government initiatives are expected to further boost the market growth during the forecast period.
-
In July 2017, Quest Diagnostics acquired Med Fusion and Clear Point laboratories in Texas for the expansion of its laboratory business for cancer diagnosis among women. The diagnosis of various diseases is made easily accessible to people owing to various collaborations among government, key players, and other agencies.
-
In November 2017, BGI and Lunenfeld-Tanenbaum Research Institute entered into a collaborative agreement to develop a genomics-based diagnostic test, which could help in early identification of women susceptible to preterm birth and other pregnancy complications.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Women’s Health Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Women’s Health Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Women’s Health Diagnostics Market - Supply Chain
4.5. Global Women’s Health Diagnostics Market Forecast
4.5.1. Women’s Health Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Women’s Health Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Women’s Health Diagnostics Market Absolute $ Opportunity
5. Global Women’s Health Diagnostics Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Women’s Health Diagnostics Market Size and Volume Forecast by Applications
5.3.1. Cancer Infectious Disease Osteoporosis Pregnancy Prenatal
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Women’s Health Diagnostics Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Women’s Health Diagnostics Market Size and Volume Forecast by End Users
6.3.1. Hospital & Diagnostics Centers Home
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Women’s Health Diagnostics Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Women’s Health Diagnostics Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Women’s Health Diagnostics Demand Share Forecast, 2019-2026
8. North America Women’s Health Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Women’s Health Diagnostics Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Women’s Health Diagnostics Market Size and Volume Forecast by Applications
8.4.1. Cancer Infectious Disease Osteoporosis Pregnancy Prenatal
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Women’s Health Diagnostics Market Size and Volume Forecast by End Users
8.7.1. Hospital & Diagnostics Centers Home
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Women’s Health Diagnostics Demand Share Forecast, 2019-2026
9. Latin America Women’s Health Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Women’s Health Diagnostics Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Women’s Health Diagnostics Market Size and Volume Forecast by Applications
9.4.1. Cancer Infectious Disease Osteoporosis Pregnancy Prenatal
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Women’s Health Diagnostics Market Size and Volume Forecast by End Users
9.7.1. Hospital & Diagnostics Centers Home
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Women’s Health Diagnostics Demand Share Forecast, 2019-2026
10. Europe Women’s Health Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Women’s Health Diagnostics Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Women’s Health Diagnostics Market Size and Volume Forecast by Applications
10.4.1. Cancer Infectious Disease Osteoporosis Pregnancy Prenatal
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Women’s Health Diagnostics Market Size and Volume Forecast by End Users
10.7.1. Hospital & Diagnostics Centers Home
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Women’s Health Diagnostics Demand Share Forecast, 2019-2026
11. Asia Pacific Women’s Health Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Women’s Health Diagnostics Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Women’s Health Diagnostics Market Size and Volume Forecast by Applications
11.4.1. Cancer Infectious Disease Osteoporosis Pregnancy Prenatal
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Women’s Health Diagnostics Market Size and Volume Forecast by End Users
11.7.1. Hospital & Diagnostics Centers Home
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Women’s Health Diagnostics Demand Share Forecast, 2019-2026
12. Middle East & Africa Women’s Health Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Women’s Health Diagnostics Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Women’s Health Diagnostics Market Size and Volume Forecast by Applications
12.4.1. Cancer Infectious Disease Osteoporosis Pregnancy Prenatal
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Women’s Health Diagnostics Market Size and Volume Forecast by End Users
12.7.1. Hospital & Diagnostics Centers Home
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Women’s Health Diagnostics Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Women’s Health Diagnostics Market: Market Share Analysis
13.2. Women’s Health Diagnostics Distributors and Customers
13.3. Women’s Health Diagnostics Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Siemens Healthcare Private Limited Hologic, Inc. GE Healthcare F. Hoffmann-La Roche Ltd. bioMérieux SA Koninklijke Philips N.V. Abbott BD
Methodology
Related Reports
Some other reports from this category!
Our Clients
